News
TipRanks on MSN11h
Alphamab Oncology’s JSKN022 IND Application Accepted by CDE
Alphamab Oncology ( ($HK:9966) ) has shared an update. Alphamab Oncology announced that its Investigational New Drug application for JSKN022, a ...
Arkansas' state laws that ban public school students from using cellphones from "bell to bell," allow the state Department of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback